RG - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Image for trademark with serial number 90981041
Serial Number
90981041
Word Mark
RG
Status
748 - Statement Of Use - To Examiner
Status Date
2024-05-08
Filing Date
2021-08-24
Mark Drawing
3 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Design Searches
260129, 270305 - Helixes. Representations of objects forming letters or numerals, including punctuation.
Published for Opposition Date
2022-08-23
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
STEEL, ALYSSA PALADINO
Statements
Description of Mark
The mark consists of a stylized illustration of the letters "R" and "G", which illustration is also meant to be a stylized presentation of the DNA double helix structure.
Goods and Services
Medical, biological, pharmaceutical, and veterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders;medical, biological, pharmaceutical, and veterinary preparations for medical and pharmaceutical use, namely, preparations for preventing and treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids for the treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; adjuvants for medical purposes; macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; a full line of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics for the treatment of infectious diseases and cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-10-10
Primary Code
005
First Use Anywhere Date
2024-02-09
First Use In Commerce Date
2024-02-09
Current Trademark Owners
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Eric Lamb Frost Brown Todd LLP
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2021-08-27NEW APPLICATION ENTERED
2021-10-10NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
2021-10-12NOTICE OF DESIGN SEARCH CODE E-MAILED
2022-05-26ASSIGNED TO EXAMINER
2022-06-09NON-FINAL ACTION WRITTEN
2022-06-09NON-FINAL ACTION E-MAILED
2022-06-09NOTIFICATION OF NON-FINAL ACTION E-MAILED
2022-07-15TEAS RESPONSE TO OFFICE ACTION RECEIVED
2022-07-15TEAS RESPONSE TO OFFICE ACTION RECEIVED
2022-07-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2022-07-15TEAS/EMAIL CORRESPONDENCE ENTERED
2022-07-15TEAS WITHDRAWAL OF ATTORNEY RECEIVED
2022-07-15WITHDRAWAL OF ATTORNEY GRANTED
2022-07-18APPROVED FOR PUB - PRINCIPAL REGISTER
2022-08-03NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2022-08-23PUBLISHED FOR OPPOSITION
2022-08-23OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2022-10-18NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2023-03-20SOU TEAS EXTENSION RECEIVED
2023-03-20SOU EXTENSION 1 FILED
2023-03-20SOU EXTENSION 1 GRANTED
2023-03-20TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2023-03-20ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2023-03-20TEAS CHANGE OF CORRESPONDENCE RECEIVED
2023-03-22NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2023-04-17TEAS CHANGE OF OWNER ADDRESS RECEIVED
2023-04-17TEAS CHANGE OF CORRESPONDENCE RECEIVED
2023-04-17APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2023-10-04ASSIGNED TO EXAMINER
2023-10-11SOU TEAS EXTENSION RECEIVED
2023-10-11SOU EXTENSION 2 FILED
2023-10-11SOU EXTENSION 2 GRANTED
2023-10-13NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2024-04-12SOU TEAS EXTENSION RECEIVED
2024-04-12TEAS REQUEST TO DIVIDE RECEIVED
2024-04-12TEAS STATEMENT OF USE RECEIVED
2024-04-23CASE ASSIGNED TO INTENT TO USE PARALEGAL
2024-04-12SOU EXTENSION 3 FILED
2024-05-08SOU EXTENSION 3 GRANTED
2024-04-12DIVISIONAL REQUEST RECEIVED
2024-05-08DIVISIONAL PROCESSING COMPLETE
2024-04-12USE AMENDMENT FILED
2024-05-08STATEMENT OF USE PROCESSING COMPLETE